Industry Publications and Presentations

Lessons Learned from COVID-19: Why CROs Must Continue Modeling Support and Compassion to Clinical Sites

The COVID pandemic has taught us that compassion is an important attribute that should be modeled amongst clinical research partners and sites to optimize business results. Learn why.

Read More
Decentralised Clinical Trials in Europe: Lessons from a Pandemic

Author: Graham Belgrave, SVP of European Operations at Advanced Clinical. Since the onset of the COVID-19 pandemic, DCTs have been critical to advancing clinical research by minimising in-person interactions. Benefits include the potential to improve recruitment, facilitate data collection, and reduce the need for travel by patients and CRAs alike, resulting in efficiencies and continued profitability. DCTs demand new roles and partnerships which will likely continue long after the pandemic comes under control. Read our feature article in the Journal of Clinical Studies to learn more.

Read More
From telemedicine to remote site visits: the post-COVID face of pharma research and development

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process. Read our article, in collaboration with pharmaphorum, to learn more.

Read More
Decentralized Clinical Trials (DCTs): Five Key Questions to Ask Your Partners to Optimize Strategy

This article addresses five essential questions clinical research partners should discuss with sponsors, sites and regulators in order to optimize the strategy and implementation of decentralized and hybrid trial models.

Read More
Five Recommendations to Make Trials More Child-Centric

While rare diseases individually affect a relatively small number of patients, as a category these diseases affect millions of people – and half of those patients are children. This article addresses why it's important to design child-centric trials to accelerate rare disease research.

Read More
Planning a Decentralized Clinical Trial

Learn how both CROs and sponsors can benefit from decentralized trial models.

Read More
Raconteur Magazine – The Future of Healthcare

Explore Graham Belgrave's comments on the challenging ethics to find a vaccine.

Read More
Future Forward Trends for Overcoming the Talent Shortage while Diminishing Risk (Innovation Theater – DIA 2020)

Learn how to proactively address the talent shortage with the right recruitment model.

Read More
Solving Immuno-Oncology Trial Challenges in the COVID-19 Era

The COVID-19 pandemic has stressed healthcare provision, but may also make major advances even more relevant.

Read More
Effective Design and Implementation of Sponsor / CRO Governance

Learn why governance boards are important, especially in the face of a pandemic like COVID-19.

Read More